Complement Therapeutics vs ONL Therapeutics
Complement Therapeutics
Developing the next generation of complement medicines
36 employees · est. 2020 · Germany
ONL Therapeutics
Helping patients see the future
39 employees · est. 2011 · Ann Arbor, United States
ONL Therapeutics is the older company (2020 vs 2011).
Side-by-Side Comparison
| Metric | Complement Therapeutics | ONL Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2011 older |
| Headquarters | ||
| Headquarters | Germany | Ann Arbor, United States |
| Employees | ||
| Employees | 36 | 39 |
| Industry | ||
| Industry | Biotechnology | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series A | Venture round |
| Total Funding | ||
| Total Funding | $77.00M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 3 | Not tracked yet |
| Services | ||
| Services | Research and development of complement-related disease therapies, Development of gene and protein-based therapeutic platforms, Mass spectrometry for complement protein measurement | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with complement-mediated diseases, Individuals with age-related macular degeneration, Healthcare providers specializing in ocular and systemic diseases | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Complement-Mediated DiseasesGene TherapyGeographic AtrophyDry Age-Related Macular DegenerationPrecision MedicineDiagnostic Platform +7 | BiopharmaceuticalTherapeuticsVisionInnovationRetinal DiseaseFas Pathway +8 |
| Website | ||
| Website | complementtx.com | onltherapeutics.com |
About Complement Therapeutics
Complement Therapeutics, founded in 2020, is a biotechnology company dedicated to pioneering the development of the next generation of complement medicines. Headquartered in Germany, this spinout from the University of Manchester focuses on innovative therapeutics for complement-mediated diseases....
About ONL Therapeutics
ONL Therapeutics is a clinical-stage biopharmaceutical company dedicated to helping patients see the future. With a mission to develop innovative therapeutics for a range of retinal diseases and conditions, the company is advancing a breakthrough technology designed to prevent the death of key retin...
Also comparing in this category
Comparing more than these two?
Get Complement Therapeutics, ONL Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Complement Therapeutics compare?
A PDF of Complement Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Complement Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Complement Therapeutics on 28 Jan 2026, and ONL Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
